Page last updated: 2024-09-03

cercosporamide and Inflammation

cercosporamide has been researched along with Inflammation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kannan, S; Nacro, K; Verma, CS; Xu, W1
Aguilar-Valles, A; Cao, R; Comai, S; De Gregorio, D; Eslamizade, MJ; Gobbi, G; Haji, N; Lacaille, JC; Luheshi, G; Matta-Camacho, E; Mechawar, N; Nadon, R; Nuñez, N; Popic, J; Rummel, C; Sharma, V; Sonenberg, N; Tanti, A; Turecki, G; Wiebe, S1

Reviews

1 review(s) available for cercosporamide and Inflammation

ArticleYear
Update on the Development of MNK Inhibitors as Therapeutic Agents.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Animals; Humans; Inflammation; Intracellular Signaling Peptides and Proteins; Neoplasms; Nervous System Diseases; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2022

Other Studies

1 other study(ies) available for cercosporamide and Inflammation

ArticleYear
Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E.
    Nature communications, 2018, 06-25, Volume: 9, Issue:1

    Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Benzofurans; Citalopram; Depression; Depressive Disorder, Major; Eukaryotic Initiation Factor-4E; Female; Fluoxetine; Inflammation; Ketamine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-KappaB Inhibitor alpha; Phosphorylation; Protein Biosynthesis; Protein Serine-Threonine Kinases; Serotonin and Noradrenaline Reuptake Inhibitors; Synaptic Transmission; Tumor Necrosis Factor-alpha

2018